SCHEMBL3201435

SCHEMBL3201435

CCOc1cc(NCc2cnns2)ccc1OC(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
MEN1 O00255 2/20 0.41
MAPK1 P28482 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 3/20 0.37
APAF1 O14727 1/20 0.37
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PRSS1 P07477 1/20 0.34
F7 P08709 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
DHFR P00374 1/20 0.34
NTRK1 P04629 1/20 0.34
PDE4B Q07343 2/20 0.34
KLK1 P06870 1/20 0.34
KLK5 Q9Y337 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3130711 0.80 BRD4 (0.49) MAPTMEN1MAPK1KMT2ALMNA
SCHEMBL3129616 0.78 MAPT (0.43) MAPTMEN1MAPK1KMT2ALMNA
SCHEMBL3131264 0.76 MAPT (0.39) MAPTMEN1MAPK1KMT2ALMNA
SCHEMBL3129664 0.75 MAPT (0.41) MAPTMEN1MAPK1KMT2ALMNA
SCHEMBL3200139 0.75 KMT2A (0.52) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL3129490 0.72 F7 (0.41) MAPTMEN1MAPK1KMT2AALDH1A1
SCHEMBL3118114 0.72 CYP3A4 (0.39) LMNARAB9ATDP1NTRK1PDE4B
SCHEMBL3201429 0.71 PDE4B (0.38) MAPTMEN1MAPK1KMT2ALMNA
SCHEMBL3131179 0.70 F2 (0.42) MAPTMEN1MAPK1KMT2AALDH1A1
SCHEMBL5673765 0.70 PDE4B (0.47) MAPTMEN1MAPK1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B MAPT 4197/4885MEN1 3385/4885MAPK1 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.